CEE (Central and Eastern Europe) countries are raising too many trade barriers in IVD (in vitro diagnostic) area
This article was originally published in Clinica
Executive Summary
As countries in central and eastern Europe approach membership of the European Union, they are now working on transposing the latest in the series of medical device directives, the In Vitro Diagnostics Directive. But they are all at very different stages and still have divergent views among themselves and with the rest of Europe about IVD regulation. Amanda Maxwell went to Prague to find out about their progress
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.